vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
30.21
-0.52 (-1.69%)
At close: Sep 25, 2026, 4:00 PM EDT
30.09
-0.12 (-0.40%)
After-hours: Sep 25, 2026, 4:10 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $375.35 million as of September 25, 2026. Its market cap has increased by 132.84% in one year.
Market Cap
375.35M
Enterprise Value
288.71M
1-Year Change
132.84%
Ranking
Category
Stock Price
$30.21
ChartMarket Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $375.35M, an increase of 380.45%. That is a compound annual growth rate of 15.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 375.35M | -24.36% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 396.24M |
| Opus Genetics | 396.01M |
| Arcturus Therapeutics Holdings | 393.66M |
| Galectin Therapeutics | 393.31M |
| Zura Bio | 387.15M |
| Agenus | 384.47M |
| Inhibikase Therapeutics | 375.07M |
| Turn Therapeutics | 372.05M |